Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services) EQUITY
$119.77
pos +0.00
+0.00%
Today's Range: 119.20 - 120.83 | EW Avg Daily Volume: 1,325,600
Last Update: 09/23/16 - 4:01 PM EDT
Volume: 0
YTD Performance: 51.65%
Open: $0.00
Previous Close: $120.87
52 Week Range: $66.57 - $121.58
Oustanding Shares: 212,878,828
Market Cap: 25,730,663,940
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 10 10
Moderate Buy 1 1 1 2
Hold 4 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.66 1.68
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 49.95
Price Earnings Comparisons:
EW Sector Avg. S&P 500
49.95 50.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
20.88% 69.17% 245.81%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.40 0.30 0.09
Net Income -39.00 0.70 0.19
EPS -39.80 0.80 0.21
Earnings for EW:
EBITDA 0.71B
Revenue 2.49B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.68 $0.73 $2.86 $3.39
Number of Analysts 13 11 12 13
High Estimate $0.72 $0.79 $2.92 $3.60
Low Estimate $0.64 $0.68 $2.84 $3.23
Prior Year $0.54 $0.63 $2.29 $2.86
Growth Rate (Year over Year) 26.67% 15.58% 24.96% 18.60%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Dan Fitzpatrick

 | Sep 23, 2016 | 11:00 AM EDT
Forget about P/E ratios; 'cheap' stocks are cheap for a reason.
RMPIA
By

Jim Cramer

 | Sep 12, 2016 | 5:44 PM EDT
These are my top fall-and-rise stories for the 10 days leading up to and immediately following next week's Federal Reserve meeting.
RMPIA
By

Dan Fitzpatrick

 | Aug 29, 2016 | 11:00 AM EDT
But these 3 other stocks are looking good for buys.

bullishEdwards Lifesciences upgraded at BofA/Merrill

Jul 27, 2016 | 8:17 AM EDT
EW was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $130 price target. Company has clear business momentum.
By

Bruce Kamich

 | Jul 18, 2016 | 12:05 PM EDT
Overall market and industry action could determine EW's next course.
RMPIA
By

Jim Cramer

 | Jul 18, 2016 | 6:00 AM EDT
Let me give you the unassailable themes.
By

Real Money

 | Jul 6, 2016 | 1:52 PM EDT

Oil began to rebound Wednesday from steep declines earlier this week.

By

Bruce Kamich

 | May 24, 2016 | 3:34 PM EDT

A pullback to $90 or even to $80 would not be extreme.

By

Jim Cramer

 | Apr 4, 2016 | 11:52 AM EDT
TheStreet's Jim Cramer says keep an eye this week on speeches by Federal Reserve presidents and go stock shopping on any weakness.
By

Jim Cramer

 | Apr 4, 2016 | 11:15 AM EDT
Edwards Lifesciences' Sapien 3 heart valve will soon be the standard for heart doctors worldwide, says Jim Cramer.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.